uraemia

[jʊ'ri:mi:ə][jʊə'ri:mjə]

n.尿毒症

  • The peritoneal dialysis machine is a medical equipment used for treating acute renal failure chronic renal failure and uraemia .

    腹膜透析机是治疗急性肾功能衰竭、慢性肾功能衰竭和 尿毒症的医疗设备。

  • The Relationship between Parathyroid Hormone ( PTH ) Level and Nutritional Status of Patients with Uraemia

    尿毒症患者甲状旁腺素水平与营养关系的 探讨

  • Conclusions The clinical symptom will be improved and the blood Bun and Cr will be decreased for chronic renal insufficiency patients after being treated by traditional Chinese medicine ( Uraemia Prescription ) then protecting remain renal function .

    结论中药( 尿毒症方)治疗慢性肾功能不 全能改善患者临床症状,降低血Bun、Cr,保护残余肾功能。

  • Middle molecular substances ( MMS ) were gel-chromagraphically separated from the plasma of uraemia patients and then injected into rats'tail veins to study the effect on myocardial contractility .

    用凝胶层析法分离出 尿毒血症患者血浆中分子物质(MMS),经尾静脉注入大鼠体内,观察MMS对大鼠心肌收缩能力的影响。

  • The study of chromosomal fragile sites in chronic glomerulonephritis uraemia

    慢性肾炎 尿毒症 患者染色体脆性位点的 初步研究

  • Analyzing the Cause of 45 Patients with Uraemia Died of Hemodialysis

    45例 尿毒症 患者血液透析死亡原因分析

  • Application value of hemofiltration on patients with neuropsychic symptoms in telophase of uraemia

    血液滤过在伴神经精神症状终末期 尿毒症 患者中应用价值的 探讨

  • Objective : To probe rescue and nurse on children with hemolysis and uraemia syndrome .

    目的:探讨小儿溶血 尿毒综合征救护体会。

  • Clinical meaning of UCG dynamic monitoring when operating hemodialysis for uraemia patients

    动态监测超声心动图在 尿毒症血液透析患者中的临床意义

  • Effect of middle molecular substances from the plasma of uraemia patients on rats ' cardiac function

    尿毒症病人血浆中分子物质对大鼠心功能的影响

  • Clinical Nursing of Hemodialysis about 40 Patients with Uraemia

    40例 尿毒症 患者血液透析的临床护理

  • Study on the Expression of TNF - α Fatty Tissues and Serum for Uraemia Patients The relationship of tumor necrosis factor-alpha and non-alcoholic fatty liver diseases complicated with metabolic syndrome

    脂肪 性及血清肿瘤坏死因子-α与 尿毒症 胰岛素 抵抗关系肿瘤坏死因子α与非酒精性脂肪肝并代谢综合征的关系研究

  • Permanent pacemaker implanted in two uraemia cases with hemodialysis

    尿毒症维持血液透析患者永久性起搏器植入两例

  • Nerve of the uraemia brain and the essence symptom observation and nursing care

    尿毒症脑病的神经及精神症状的观察与护理

  • Analysis Integrated TCM WM Therapy for Neuropsychic Symptoms of Uraemia in Telophase

    终末期 尿毒症神经精神症状分析及中西医结合治疗

  • The operation is contraindicated in patients with uraemia .

    进入 尿毒症 的患者禁忌施行此术。

  • The prognosis of diabetic renopathy is not good especially for those in the period of uraemia .

    糖尿病肾病预后不良,特别是 进入 尿毒症期更为 严重

  • Conclusion PTH can impact nutritional status of uraemia patients ;

    结论PTH是影响 尿毒症患者营养状况的 重要 尿 毒素

  • Remove Middle Molecular Substance of Uraemia with Blood Adsorption

    血液吸附对 尿毒症中分子物质清除的 临床 观察

  • Serum AGE levels were no significantly different between uraemia with and without dialyse ( P > 0.05 ) .

    尿素症透析组与非透析组 AGE无显著性差异(P>0.05)。

  • The clinical significance of trace element contents changing in uraemia patients serum and hair

    尿毒症患者血清及头发中微量元素含量变化的临床意义

  • Nursing for patients with uraemia pruritus treated by applying On-line blood dialysis filtration

    应用On-line血液透析滤过治疗 尿毒症瘙痒的护理

  • Renal transplantation is a very effective way to treat uraemia .

    肾移植是治疗 尿毒症的一种非常有效的方法。

  • Preliminary study to metabolism of microelements zn cu and Al in the serum of uraemia patients

    尿毒症患者血清中Zn,Cu,Al的代谢

  • Conclusion The positive rate of ACL in patients with nephrotic syndrome is significantly higher than that of normal controls and patients with latent nephritis or uraemia .

    结论ACL在原发性肾病综合征病人中的阳性率明显高于正常人及隐匿性肾炎和 尿毒症病人。

  • Haemolytic uraemic syndrome ( HUS ) is a life-threatening disease characterized by acute renal failure ( uraemia ) haemolytic anaemia and a low platelet count ( thrombocytopenia ) .

    溶血性尿毒综合征是一种危及生命的疾病,其特征是急性肾功能衰竭( 尿毒症)、溶血性贫血以及低血小板(血小板减少症)。

  • Method 45 death cases selected among 327 patients with uraemia were retrospectively summarized and analyzed .

    方法:对327例 尿毒症患者中45例死亡病例进行回顾性总结、分析。

  • Methods Serum AGE was measured by enzyme linked immunoadsorbent assay ( ELISA ) in 62 diabetic patients which were divided into three groups : diabetes without nephropathy DN and uraemia with and without dialyse ; 30 healthy served controls .

    方法将62例糖尿病(DM)患者分为DM无肾病组、DN组( 尿毒症透析组和非透析组),并设30例体检正常者做对照组,采用ELISA法进行血清AGE检测。

  • The effective rate of treatment was 50.4 % it might be related with the early or late stage of uraemia etiology reversible factors .

    治疗有效率50.4%。 疗效 尿毒症 早晚发病及有无可逆因素有密切关系。